Choroidal Neovascular Membrane in Age-Related Macular Degeneration is Associated with Increased Interleukin-6

Seddon, 2005, Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6 and, and other cardiovascular biomarkers, Arch Ophthalmol, 123, 774, 10.1001/archopht.123.6.774 Koto, 2007, Eicospentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice, Invest Ophthalmol Vis Sci, 48, 4328, 10.1167/iovs.06-1148 Penfold, 2001, Immunological and aetiological aspects of macular degeneration, Prog Retin Eye Res, 20, 385, 10.1016/S1350-9462(00)00025-2 Hageman, 2001, An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE–Brunch’s membrane interface in aging and age-related macular degeneration, Prog Retin Eye Res, 20, 705, 10.1016/S1350-9462(01)00010-6 Anderson, 2002, A role of for local inflammation in the formation of drusen in the aging eye, Am J Ophthalmol, 134, 411, 10.1016/S0002-9394(02)01624-0 Lip, 2001, Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction, Ophthalmology, 108, 705, 10.1016/S0161-6420(00)00663-1 Wang, 2009, Amoyloid-β up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: another mechanism of complement activation in age-related macular degeneration, J Cell Physiol, 220, 119, 10.1002/jcp.21742 Mukesh, 2004, Five-year incidence of age-related maculopathy: the visual impairment Project, Ophthalmology, 111, 1176, 10.1016/j.ophtha.2003.08.042 Kannel, 1992, White blood cell count and cardiovascular disease. Insights from the Framingham Study, JAMA, 267, 1253, 10.1001/jama.1992.03480090101035 Seddon, 2003, Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio, Arch Ophthalmol, 121, 785, 10.1001/archopht.121.6.785 Johnson, 2000, A potential role for immune complex pathogenesis in drusen formation, Exp Eye Res, 70, 441, 10.1006/exer.1999.0798 Mullins, 2000, Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease, FASEB J, 14, 835, 10.1096/fasebj.14.7.835 Johnson, 2001, Complement activation and inflammatory processes in drusen formation and age related macular degeneration, Exp Eye Res, 73, 887, 10.1006/exer.2001.1094 Seddon, 2004, Association between C-reactive protein and age-related macular degeneration, JAMA, 291, 704, 10.1001/jama.291.6.704 Klein, 2003, Early age-related maculopathy in the Cardiovascular Health Study, Ophthalmology, 110, 25, 10.1016/S0161-6420(02)01565-8 Klein, 1999, Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study, Arch Ophthalmol, 117, 1203, 10.1001/archopht.117.9.1203 Cohen, 1996, Interleukin 6 induces the expression of vascular endothelial growth factor, J Biol Chem, 271, 736, 10.1074/jbc.271.2.736 Marruo, 1992, IL-6 increases endothelial permeability in vitro, Endocrinology, 131, 710 Hattenbach, 2002, Detection of inducible nitric oxide synthase and vascular endothelial growth factor in choroidal neovascular membranes, Ophthalmologica, 216, 209, 10.1159/000059634 Bories, 1995, Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase, Clin Chem, 41, 904, 10.1093/clinchem/41.6.904 Miranda, 2001, Nitric oxide, Biol Chem, 5, 62 Ding, 2009, Molecular pathology of age-related macular degeneration, Prog Retin Eye Res, 28, 1, 10.1016/j.preteyeres.2008.10.001 Tsai, 2008, Interleukin gene polymorphisms in age-related macular degeneration, Invest Ophthalmol Vis Sci, 49, 693, 10.1167/iovs.07-0125 Gragoudas, 2004, Pegaptanib for neovascular age-related macular degeneration, N Engl J Med, 351, 2805, 10.1056/NEJMoa042760 Rosenfeld, 2006, Ranibizumab for neovascular age-related macular degeneration, N Engl J Med, 355, 1419, 10.1056/NEJMoa054481 Miyamoto, 2000, Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1), Am J Pathol, 156, 1733, 10.1016/S0002-9440(10)65044-4 Ishida, 2003, VEGF164 is proinflammatory in the diabetic retina, Invest Ophthalmol Vis Sci, 44, 2155, 10.1167/iovs.02-0807 Izumi-Nagai, 2007, Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization, Am J Pathol, 170, 2149, 10.2353/ajpath.2007.061018 Nowak, 2006, Age-related macular degeneration (AMD): pathogenesis and therapy, Pharmacol Rep, 58, 353 Roh, 2009, Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with and after bevacizumab treatment, Retina, 29, 523, 10.1097/IAE.0b013e318195cb15 Lutty, 1996, Localization of vascular endothelial growth factor in human retina and choroid, Arch Ophthalmol, 114, 971, 10.1001/archopht.1996.01100140179011 Cubitt, 1995, Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes, Invest Ophthalmol Vis Sci, 36, 330 Fanatsu, 2002, Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema, Am J Ophthalmol, 133, 70, 10.1016/S0002-9394(01)01269-7 Hoekzema, 1992, Endotoxin-induced uveits in the rat. The significance of intraocular interleukin-6, Invest Ophthalmol Vis Sci, 33, 532 Goldstein, 1996, Nitric oxide: a review of its role in retinal function and disease, Vision Res, 36, 2979, 10.1016/0042-6989(96)00017-X Moncada, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109 RayChaudhury, 1996, Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide, J Cell Biochem, 63, 125, 10.1002/(SICI)1097-4644(19961101)63:2<125::AID-JCB1>3.0.CO;2-# Shima, 1995, Hypoxic induction of endothelial growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen, Mol Med, 1, 182, 10.1007/BF03401566 Papapetropoulos, 2001, Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells, J Clin Invest, 107, 945 Ziche, 1997, Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis, J Clin Invest, 99, 2625, 10.1172/JCI119451 Tsurumi, 1997, Reciprocal relation between VEGF and NO in the regulation of endothelial integrity, Nat Med, 3, 879, 10.1038/nm0897-879 Aiello, 1997, Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor, Diabetes, 46, 1473, 10.2337/diab.46.9.1473 Punglia, 1997, Regulation of vascular endothelial growth factor expression by insulin-like growth factor I, Diabetes, 46, 1619, 10.2337/diacare.46.10.1619